1 Product identity
Ingredient risk
2 ingredients to use with caution
Ferro-Sequels High Potency Iron Supplement
BrandFerro-Sequels→Single Vitamin and Mineral Other (e.g. tea bag) 9 ingredients 2 caution DSLD #64129Net contents: 100 Caplet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2016-08-24
2 Ingredients (9)
IngredientGroupSafety
LactoseLactose—
Microcrystalline CelluloseCellulose—
Contains 2% or less of:Header—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Iron — Iron supplementation in iron-replete patients may increase cardiovascular and cancer risk — always document deficiency before prescribing [1].
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Vitamin C — Generally Safe
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Iron — Use with Caution
⚠ GI upset, constipation
⚠ Fatal toxicity in children
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID64129
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2016-08-24
6 More from Ferro-Sequels
View Ferro-Sequels Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Ferro-Sequels High Potency Iron Supplement — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 15]. Available from: https://supplement.ge/products/ferro-sequels-high-potency-iron-supplement-64129/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG